These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8563699)

  • 41. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M; Provost D; Versigny A; Cloarec A
    Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography.
    Zhuo J; Song K; Abdelrahman A; Mendelsohn FA
    Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):557-67. PubMed ID: 7982288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
    Widdop RE; Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
    Hilditch A; Hunt AA; Gardner CJ; Twissell DJ; Polley J; Travers A; Drew GM; Middlemiss D; Ross BC; Robertson MJ
    Br J Pharmacol; 1994 Jan; 111(1):137-44. PubMed ID: 8012689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
    Ohtawa M; Takayama F; Saitoh K; Yoshinaga T; Nakashima M
    Br J Clin Pharmacol; 1993 Mar; 35(3):290-7. PubMed ID: 8471405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive activity and pharmacokinetics of KD3-671, a nonpeptide AT1-receptor antagonist, in renal hypertensive dogs.
    Takata Y; Tajima S; Mochizuki S; Suzaka H; Tomiyama A; Kato H
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):834-44. PubMed ID: 9821859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacological characterization of FK 739, a new angiotensin II-receptor antagonist.
    Hamada K; Nakajima Y; Nirei H; Nakajima C; Nagashima A; Sogabe K; Notsu Y; Ono T
    Jpn J Pharmacol; 1993 Nov; 63(3):335-43. PubMed ID: 8107326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
    McMahon EG; Yang PC; Babler MA; Suleymanov OD; Palomo MA; Olins GM; Cook CS
    Am J Hypertens; 1997 Jun; 10(6):671-7. PubMed ID: 9194514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacology of LR-B/057, a novel orally active AT1 receptor antagonist.
    Renzetti AR; Cucchi P; Guelfi M; Cirillo R; Salimbeni A; Subissi A; Giachetti A
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):354-60. PubMed ID: 7769798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
    Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE
    Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.
    Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Schorn TW; Schaffer LW; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ
    Am J Hypertens; 1995 Jan; 8(1):58-66. PubMed ID: 7734099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    Chang RS; Siegl PK; Clineschmidt BV; Mantlo NB; Chakravarty PK; Greenlee WJ; Patchett AA; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):133-8. PubMed ID: 1625192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
    Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of BIBS 39 and BIBS 222: two new nonpeptide angiotensin II receptor antagonists.
    Zhang J; Entzeroth M; Wienen W; Van Meel JC
    Eur J Pharmacol; 1992 Jul; 218(1):35-41. PubMed ID: 1397034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist.
    Chi YH; Lee JH; Kim JH; Tan HK; Kim SL; Lee JY; Rim HK; Paik SH; Lee KT
    Biol Pharm Bull; 2013; 36(7):1208-15. PubMed ID: 23811571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.